ResearcherUniversity Hospital ZurichNo recent work listed

Anurag Kumar Gupta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6850-3489; OpenAlex author ID A5100601190. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer. Last author DOI 10.1038/s41388-022-02182-4 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Karolina S. Jabbar · 1 shared paper, 2022 · strength 0.12
- Paper De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer. DOI 10.1038/s41388-022-02182-4 ↗
Sabrina Steiner · 1 shared paper, 2022 · strength 0.12
- Paper De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer. DOI 10.1038/s41388-022-02182-4 ↗
Daniela M. Lenggenhager · 1 shared paper, 2022 · strength 0.12
- Paper De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer. DOI 10.1038/s41388-022-02182-4 ↗
Dilmurodjon Eshmuminov · 1 shared paper, 2022 · strength 0.12
- Paper De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer. DOI 10.1038/s41388-022-02182-4 ↗
Stephan A. Hahn · 1 shared paper, 2022 · strength 0.12
- Paper De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer. DOI 10.1038/s41388-022-02182-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.